CALCIUM CHLORIDE INJECTION

The Defense Logistics Agency awarded a single-line-item delivery order, SPE2D926F7451, to CARDINAL HEALTH, INC. (CAGE 00E55) on July 20, 2026, for the supply of one unit of Calcium Chloride Injection (NSN 6505015037386, NDC 76329-3304-01) at a fixed price of $83.35 under the basic ordering agreement SPE2DX25D8022. The delivery is FOB destination to USS CHARLESTON LCS 18, with the contractor bearing all freight costs and responsibility until physical receipt at the delivery point, after which the government assumes title and risk. The item must be shipped by the fastest traceable means, excluding parcel post, and all packaging and documentation must reference the identification numbers from the delivery order. Payment is governed by DFARS 252.232-7003, requiring electronic invoicing through Wide Area Workflow, with eligibility for Fast Pay Net 15 terms if submitted correctly. The awardee is certified as a Small Disadvantaged Woman-Owned Business and must maintain active status in the System for Award Management, with potential subcontracting plan requirements under FAR and DFARS small business rules. The product’s compliance is implicitly tied to federal medical supply standards through its NSN and NDC identifiers, though no explicit USP, ASTM, or MIL-STD specifications are stated. Inspection and acceptance are the government’s responsibility at the destination, controlled by the Contracting Officer Lisa Quinn, while Michelle Pampel serves as the local administrative contact for DLA Troop Support in Philadelphia. The contract includes no options, variations, or special requirements beyond standard logistics and payment protocols. No formal contract clauses beyond payment terms, no additional attachments, and no evaluation factors beyond award are documented, indicating a highly streamlined, transactional procurement focused solely on fulfilling a single medical supply need.